[The use of oral futraful as secondary treatment of patients with metastatic carcinoma].
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives*; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy*; D010307:Parotid Neoplasms / Q000188:drug therapy; D005641:Tegafur / Q000627:therapeutic use*; D013964:Thyroid Neoplasms / Q000188:drug therapy
D005641:Tegafur; D005472:Fluorouracil
Impiego del futraful orale come trattamento secondario in pazienti affetti da carcinoma metastatico.